What Fueled The Previous Growth In The Biologic Imaging Reagents Market?
The biologic imaging reagents market has seen considerable growth due to a variety of factors.
• There has been a significant expansion in the size of the biologic imaging reagents market in the past few years. The market, which is projected to increase from $18.41 billion in 2024 to $20.26 billion in 2025, will boast a compound annual growth rate (CAGR) of 10.0%.
The past growth can be credited to a higher prevalence of chronic illnesses, increases in research and development funding, a transition to personalized healthcare, a preference for early disease identification, a rise in the elderly population, and partnerships in biomedical study.
What Can Be Expected from the Biologic Imaging Reagents Market Size?
The biologic imaging reagents market is expected to maintain its strong growth trajectory in upcoming years.
• The market for biologic imaging reagents is set to witness considerable expansion in the coming years, with expectations that it will elevate to $27.78 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.2%.
The projected growth within these years can be associated with factors such as wider use in drug development, increased need for molecular imaging, emphasis on non-invasive diagnostic techniques, a worldwide rise in cancer occurrences, and a transition towards value-based healthcare systems. Key trends during this forecast period consist of growing demand for contrast-enhanced imaging agents, advancements in targeted molecular imaging agents, the use of nanoparticles in imaging, the advent of fluorescent probes for in vivo imaging, and the incorporation of artificial intelligence in image analysis.
What Are the Critical Driver Fuelling The Biologic Imaging Reagents Market's Growth?
The rise in chronic illnesses is predicted to stimulate the biologic imaging reagents market's expansion. Chronic disorders are conditions which persist for more than a year, necessitating ongoing medical treatment that may intensify with time. Biologic imaging reagents are used in these chronic diseases to visualize affected organs and structures for diagnosis and disease detection. To exemplify, the American Cancer Society projected in 2022 that there would be roughly 1.9 million new cancer diagnoses and 609,360 cancer fatalities in the United States. Similarly, the National Library of Medicine projected in January 2023 that the number of Americans over the age of 50 with at least one chronic condition is set to climb by 99.5% by 2050, from 71.522 million to 142.66 million. The escalating prevalence of chronic diseases is therefore a key driver of growth in the biologic imaging reagents market.
Biologic Imaging Reagents Market Driver: Influential Impact of Biologic Imaging Reagents in Growth of Personalized Medicine Landscape
How Is The Biologic Imaging Reagents Market segmented?
The biologic imaging reagents market covered in this report is segmented –
1) By Product: Contrast Reagents, Optical Imaging Reagents, Radiopharmaceuticals
2) By Modality: Magnetic Resonance Imaging (MRI), Ultrasound, X-Ray And Computerized Tomography (CT), Nuclear, Optical Imaging, Other Modalities
3) By Application: In Vitro, In Vivo
4) By End User: Diagnostic Laboratories, Imaging Centers, Life Science Companies, Research And Academic Institutes, Other End Users
Subsegments:
1) By Contrast Reagents: X-ray Contrast Agents, MRI Contrast Agents, Ultrasound Contrast Agents
2) By Optical Imaging Reagents: Fluorescent Dyes, Bioluminescent Reagents, Quantum Dots
3) By Radiopharmaceuticals: Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals
Pre-Book The Biologic Imaging Reagents Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Biologic Imaging Reagents Market?
Key players in the biologic imaging reagents market, such as Becton, Dickinson, and Company, are putting focus on the creation of innovative reagents like novel dye technology. This new technology provides a fresh tool for researchers and clinicians to elevate the specificity and sensitivity of biological imaging. Developing new dyes for a range of different applications, including biological imaging, is what novel dye technology entails. For example, in April 2022, the US-based medical device company, Becton, Dickinson, and Company, introduced BD Horizon RealYellow 586 Reagents and RealBlue Reagents. These new reagents provide researchers with the ability to attain a higher level of data resolution and a deeper understanding of their samples compared to standard fluorochrome. This elevation in performance happens because of the use of revolutionary dye technology and artificial intelligence. Artificial Intelligence evaluates existing data from excitation and emission profiles of commercially available fluorochromes and subsequently decides the most suitable laser lines for creating new dyes.
Who Are the Key Players In The Biologic Imaging Reagents Market?
Major companies operating in the biologic imaging reagents market report are:
• Cardinal Health Inc.
• Johnson And Johnson Services Inc.
• Bayer Healthcare AG
• Thermo Fisher Scientific Inc.
• Siemens Healthcare GmbH
• Dickinson and Company (BD)
• Koninklijke Philips N.V.
• GE HealthCare Technologies Inc.
• Stryker Corporation
• FluoroPharma Medical Inc.
• Lonza Group AG
• Illumina Inc.
• PerkinElmer Inc.
• Becton
• Dickinson and Company
• Bio-Rad Laboratories Inc.
• Bracco Diagnostics Inc.
• Leica Microsystems GmbH
• Lantheus Medical Imaging Inc.
• Guerbet SA
• Miltenyi Biotec B.V. and Co. KG
• Promega Corporation
• Abcam plc.
• Luminex Corporation
• MILabs
• LI-COR Biosciences
• FUJIFILM VisualSonics Inc.
• Advanced Proteome Therapeutics Incorporated
• BIOPRO Baden-Württemberg GmbH
• ABX Advanced Biochemical Compounds GmbH
What Is The Most Dominant Region In The Biologic Imaging Reagents Market?
North America was the largest region in the biologic imaging reagents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologic imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
